Swiss Capital – Brokerul Tău pe Piața de Capital
  • News
  • Research
  • About Us
  • Why Should I Invest?
  • English
    • English

ATB RO: 2026–2028 budget implies modest recovery, not a Strategy 2030 run-rate | NEUTRAL

by Stoian Cosmin 04/28/2026
04/28/2026
22
Download
File Type: pdf
File Size: 47 Ko
Categories: Antibiotice S.A.
previous post
SNG RO: Q1 2026 key operating indicators
next post
SNG RO: Weak volume outlook drives 2026 budgeted profit drop; budget more cautious than expected | NEGATIVE

Last Articles

  • Trading Taxes and the Unique Tax Return – A Swiss Capital & Think Tax Webinar

    04/03/2026

  • SHARE CAPITAL INCREASE – STAR RESIDENCE INVEST S.A.

    03/05/2026

  • Public Tender Offer for the Shares of INFINITY CAPITAL INVESTMENTS S.A.

    03/04/2026

  • Public Tender Offer for the Shares of LION CAPITAL S.A.

    02/27/2026

  • Public Tender Offer for the Shares of LONGSHIELD INVESTMENT GROUP S.A.

    02/27/2026
Swiss Capital – Brokerul Tău pe Piața de Capital
  • News
  • Research
  • About Us
  • Why Should I Invest?
  • English
    • English
Investments on the capital market involve risks, and before making the decision to invest, it is necessary to consider the financial objectives, the level of experience and the appetite for risk. The analyses, studies, opinions, news, prices or any other information available on the site do not constitute trading recommendations. The content of the website can be changed without prior notice

© 2011-2026 Swiss Capital -All rights reservedDeveloped by HyperSense-Software